Today: 21 May 2026
Browse Category

LSE:BP.L 3 November 2025 - 18 January 2026

BP stock jumps with oil prices as buyback rolls on — here’s what investors watch next

BP stock jumps with oil prices as buyback rolls on — here’s what investors watch next

BP shares closed up 2.39% at 426 pence Friday, buoyed by a 2.18% rise in Brent crude to $63.34 a barrel amid supply concerns linked to Iran and the Russia-Ukraine war. BP repurchased over 3.1 million shares as part of its ongoing buyback. Norges Bank cut its BP voting rights to 2.999%. The FTSE 100 ended at a record high, with energy stocks leading gains.
10 January 2026
FTSE 100 Forecast 2026: UK Stock Market Pulls Back From Records as Oil Slides

FTSE 100 Forecast 2026: UK Stock Market Pulls Back From Records as Oil Slides

The FTSE 100 fell 0.7% to 10,054.34 by 1052 GMT, led lower by BP and miners after recent record highs. Oil prices dropped as the U.S. announced a $2 billion Venezuelan crude deal, with Shell down 2.4% and BP off 3.1%. UK construction PMI slumped to 40.1 in December. Auction Technology rejected 11 takeover bids from FitzWalter Capital, the first such move for a UK-listed firm this year.
BP stock watch: Tiber contract, buyback and oil slide put BP PLC shares in focus

BP stock watch: Tiber contract, buyback and oil slide put BP PLC shares in focus

BP shares closed down 0.6% at 435.25 pence Monday before the London open, after TechnipFMC announced a $600 million-$800 million contract for BP’s Tiber deepwater project. BP bought 3 million shares Jan. 5 as part of its buyback program. Brent crude slipped 0.2% to $61.62 a barrel early Tuesday. BP’s Venezuela gas plans remain stalled after a U.S. licence revocation.
U.S. strikes Venezuela: What it could mean for BP, Shell and UK oil stocks on Monday

U.S. strikes Venezuela: What it could mean for BP, Shell and UK oil stocks on Monday

U.S. forces struck Venezuela and captured President Nicolas Maduro, triggering an oil embargo that has stalled the country’s crude exports. Brent crude closed at $60.75 a barrel on Friday, before the attack. Venezuela’s oil production and refining remain undamaged, but exports are paralyzed, sources said. London-listed energy shares face uncertainty as markets await the impact on oil supply and prices.
3 January 2026
UK Stock Market Today (24 December 2025): FTSE 100 Ends Flat in Christmas Eve Half‑Day as BP’s Castrol Sale, Strong Sterling and Record Metals Shape the Mood

UK Stock Market Today (24 December 2025): FTSE 100 Ends Flat in Christmas Eve Half‑Day as BP’s Castrol Sale, Strong Sterling and Record Metals Shape the Mood

The FTSE 100 closed nearly flat at 9,890.40, up 0.01%, in thin Christmas Eve trading. BP agreed to sell a 65% stake in Castrol to Stonepeak for about $6 billion, valuing Castrol at $10.1 billion. The London Stock Exchange ended its session early at 12:30pm. Sterling rose above $1.35 while precious metals extended gains.
BP plc Stock News and Forecasts (Dec. 21, 2025): Meg O’Neill Named CEO, Buyback Questions, and Analyst Targets for BP.L and NYSE:BP

BP plc Stock News and Forecasts (Dec. 21, 2025): Meg O’Neill Named CEO, Buyback Questions, and Analyst Targets for BP.L and NYSE:BP

BP named Meg O’Neill, current Woodside Energy CEO, as its next chief executive effective April 1, 2026, marking the company’s first external CEO hire in over a century. BP shares closed at 424.85p in London and $33.94 in New York on Dec. 19. Markets remain focused on O’Neill’s potential strategy changes and renewed takeover speculation. Carol Howle will serve as interim CEO until O’Neill takes over.
21 December 2025
UK Stock Market Today (16 Dec 2025): FTSE 100 Falls as Oil and Defence Shares Slide Ahead of BoE Rate Cut

UK Stock Market Today (16 Dec 2025): FTSE 100 Falls as Oil and Defence Shares Slide Ahead of BoE Rate Cut

The FTSE 100 closed down 0.7% at 9,684.79 on Tuesday, hit by a 3% drop in energy shares as Brent crude fell below $60 a barrel. Defence stocks also retreated, with BAE Systems down 1.9% and Babcock off 4.1%, amid renewed Russia–Ukraine peace talk optimism. The FTSE 250 was little changed. Investors weighed weaker UK jobs data ahead of the Bank of England’s rate decision.
Most Active UK Stocks Today (9 December 2025): BP, Barclays, Rolls‑Royce, Unilever and More in Focus

Most Active UK Stocks Today (9 December 2025): BP, Barclays, Rolls‑Royce, Unilever and More in Focus

The FTSE 100 closed down 0.2% at 9,645.09 on Monday, with heavy trading concentrated in BP, Barclays, Rolls-Royce, Unilever, Lloyds, HSBC, London Stock Exchange Group, Anglo American, GSK, and British American Tobacco. Investors pulled back ahead of key US Federal Reserve and Bank of England rate decisions. FTSE 100 futures hovered near 9,657 early Tuesday, with technical signals pointing to caution.
Best UK Stocks to Buy Today (8 December 2025): 7 FTSE 100 Ideas for a Potential Rate‑Cut Era

Best UK Stocks to Buy Today (8 December 2025): 7 FTSE 100 Ideas for a Potential Rate‑Cut Era

The FTSE 100 closed near 9,660 on December 8, posting a total return of about 20–23% year-to-date, its best run since 2009. The Bank of England has held rates at 4% since August, with inflation at 3.6%. Markets expect a rate cut to 3.75% at the December 18 meeting. UK mortgage rates have dropped to their lowest since before September 2022.
BP PLC share price: What to know before the London market opens on 17 November 2025

BP share price today (21 November 2025): BP.L dips as Olympic Pipeline shutdown and weaker oil prices hit sentiment

BP shares closed around 450p in London on Friday, down about 1.7% after a major U.S. pipeline leak and weaker oil prices. The Olympic Pipeline in Washington state remains fully shut after a 11 November leak, with no timeline for restart. Trading volume reached 7–8 million shares. The shutdown has disrupted jet fuel supplies to Seattle-Tacoma International Airport.
London Stock Exchange at Record Highs – Inside the Historic Market’s Brexit Battle and 2025 Revival

London Markets Slip as FTSE 100 Falters Ahead of BoE Verdict

The FTSE 100 closed at 9,701, down 0.2%, pausing near record highs as gains in oil and financial stocks were offset by losses in mining and retail. The FTSE 250 slipped 0.3%. Investors grew cautious ahead of Thursday’s Bank of England meeting. Vodafone fell over 5% after a broker downgrade, while BP rose 1% after a $1.5 billion US asset sale.

Stock Market Today

  • Stock Market Today: Key Insights for May 21 Trading
    May 20, 2026, 10:27 PM EDT. Stocks in the news and major brokerage calls shape market sentiment as traders prepare for May 21. This report provides a complete trade setup, highlighting critical market movements and strategies. Stay informed with the essential data before entering trades today.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop